nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—portal vein—stomach cancer	0.14	0.35	CbGeAlD
Alendronate—PTPRE—vein—stomach cancer	0.0806	0.201	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—FGG—stomach cancer	0.0185	0.087	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IRF1—stomach cancer	0.0143	0.0673	CbGpPWpGaD
Alendronate—PTPRE—hematopoietic system—stomach cancer	0.0136	0.034	CbGeAlD
Alendronate—PTPN4—hematopoietic system—stomach cancer	0.013	0.0323	CbGeAlD
Alendronate—PTPRS—ECM proteoglycans—ITGA8—stomach cancer	0.0115	0.054	CbGpPWpGaD
Alendronate—PTPN4—digestive system—stomach cancer	0.00901	0.0225	CbGeAlD
Alendronate—PTPRE—bone marrow—stomach cancer	0.00873	0.0218	CbGeAlD
Alendronate—PTPN4—bone marrow—stomach cancer	0.0083	0.0207	CbGeAlD
Alendronate—PTPRE—endocrine gland—stomach cancer	0.00782	0.0195	CbGeAlD
Alendronate—PTPN4—endocrine gland—stomach cancer	0.00744	0.0186	CbGeAlD
Alendronate—PTPRS—ECM proteoglycans—SPARC—stomach cancer	0.00739	0.0348	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6ST—stomach cancer	0.00735	0.0346	CbGpPWpGaD
Alendronate—PTPRS—bone marrow—stomach cancer	0.00712	0.0178	CbGeAlD
Alendronate—PTPRE—liver—stomach cancer	0.00705	0.0176	CbGeAlD
Alendronate—Histamine Phosphate—HRH4—stomach cancer	0.00702	0.521	CrCbGaD
Alendronate—PTPN4—liver—stomach cancer	0.00671	0.0167	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—IL6R—stomach cancer	0.00656	0.0309	CbGpPWpGaD
Alendronate—ATP6V1A—hematopoietic system—stomach cancer	0.0064	0.016	CbGeAlD
Alendronate—PTPRS—endocrine gland—stomach cancer	0.00638	0.0159	CbGeAlD
Alendronate—PTPRS—liver—stomach cancer	0.00575	0.0143	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—ICAM2—stomach cancer	0.0057	0.0268	CbGpPWpGaD
Alendronate—PTPRE—lymph node—stomach cancer	0.00541	0.0135	CbGeAlD
Alendronate—ATP6V1A—pancreas—stomach cancer	0.00521	0.013	CbGeAlD
Alendronate—PTPN4—lymph node—stomach cancer	0.00514	0.0128	CbGeAlD
Alendronate—FDPS—Activation of gene expression by SREBF (SREBP)—SREBF2—stomach cancer	0.00509	0.024	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—JUN—stomach cancer	0.00484	0.0228	CbGpPWpGaD
Alendronate—FDPS—hematopoietic system—stomach cancer	0.00482	0.012	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—MMP10—stomach cancer	0.00464	0.0219	CbGpPWpGaD
Alendronate—ATP6V1A—lymphoid tissue—stomach cancer	0.00451	0.0112	CbGeAlD
Alendronate—ATP6V1A—digestive system—stomach cancer	0.00445	0.0111	CbGeAlD
Alendronate—PTPRS—lymph node—stomach cancer	0.00441	0.011	CbGeAlD
Alendronate—FDPS—smooth muscle tissue—stomach cancer	0.00425	0.0106	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—STAT3—stomach cancer	0.00418	0.0197	CbGpPWpGaD
Alendronate—ATP6V1A—bone marrow—stomach cancer	0.0041	0.0102	CbGeAlD
Alendronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—SREBF2—stomach cancer	0.00406	0.0191	CbGpPWpGaD
Alendronate—FDPS—pancreas—stomach cancer	0.00393	0.0098	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—MYC—stomach cancer	0.00389	0.0183	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—PRKAB1—stomach cancer	0.00387	0.0182	CbGpPWpGaD
Alendronate—ATP6V1A—endocrine gland—stomach cancer	0.00368	0.00918	CbGeAlD
Alendronate—FDPS—lymphoid tissue—stomach cancer	0.00339	0.00847	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—ITGA5—stomach cancer	0.00339	0.016	CbGpPWpGaD
Alendronate—Zoledronate—CA2—stomach cancer	0.00336	0.249	CrCbGaD
Alendronate—FDPS—digestive system—stomach cancer	0.00335	0.00837	CbGeAlD
Alendronate—ATP6V1A—liver—stomach cancer	0.00332	0.00827	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—PIK3CA—stomach cancer	0.0033	0.0155	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—SREBF2—stomach cancer	0.00329	0.0155	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ITGA8—stomach cancer	0.00327	0.0154	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PRKAB1—stomach cancer	0.00319	0.015	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—SERPINE1—stomach cancer	0.00311	0.0147	CbGpPWpGaD
Alendronate—FDPS—bone marrow—stomach cancer	0.00309	0.00771	CbGeAlD
Alendronate—ATP6V1A—Iron uptake and transport—HMOX1—stomach cancer	0.00308	0.0145	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—BMP7—stomach cancer	0.00299	0.0141	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—PRKAA1—stomach cancer	0.00293	0.0138	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—stomach cancer	0.00292	0.0138	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—RBP4—stomach cancer	0.00283	0.0133	CbGpPWpGaD
Alendronate—FDPS—endocrine gland—stomach cancer	0.00277	0.00691	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—FGG—stomach cancer	0.00267	0.0126	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CTSL—stomach cancer	0.00254	0.012	CbGpPWpGaD
Alendronate—ATP6V1A—lymph node—stomach cancer	0.00254	0.00634	CbGeAlD
Alendronate—FDPS—liver—stomach cancer	0.0025	0.00623	CbGeAlD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PRKAA1—stomach cancer	0.00242	0.0114	CbGpPWpGaD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—stomach cancer	0.00213	0.01	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—SPARC—stomach cancer	0.00211	0.00993	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—BMP2—stomach cancer	0.00211	0.00993	CbGpPWpGaD
Alendronate—FDPS—lymph node—stomach cancer	0.00192	0.00478	CbGeAlD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00189	0.00889	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CD44—stomach cancer	0.00179	0.00844	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—RPS6—stomach cancer	0.00173	0.00814	CbGpPWpGaD
Alendronate—Risedronate—PTGS2—stomach cancer	0.00164	0.121	CrCbGaD
Alendronate—Clodronate—PTGS2—stomach cancer	0.00146	0.108	CrCbGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—FGFR2—stomach cancer	0.00119	0.0056	CbGpPWpGaD
Alendronate—FDPS—SREBP signalling—PPARG—stomach cancer	0.00112	0.0053	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IRS2—stomach cancer	0.00109	0.00513	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.00102	0.00482	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6ST—stomach cancer	0.001	0.00471	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CDH1—stomach cancer	0.000939	0.00442	CbGpPWpGaD
Alendronate—Asthma—Capecitabine—stomach cancer	0.000911	0.00244	CcSEcCtD
Alendronate—Dysphagia—Capecitabine—stomach cancer	0.000911	0.00244	CcSEcCtD
Alendronate—Influenza like illness—Doxorubicin—stomach cancer	0.000909	0.00243	CcSEcCtD
Alendronate—Erythema—Fluorouracil—stomach cancer	0.000909	0.00243	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP2—stomach cancer	0.000904	0.00426	CbGpPWpGaD
Alendronate—Photosensitivity—Methotrexate—stomach cancer	0.000894	0.00239	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6R—stomach cancer	0.000893	0.00421	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—SERPINE1—stomach cancer	0.000887	0.00418	CbGpPWpGaD
Alendronate—Ill-defined disorder—Irinotecan—stomach cancer	0.00088	0.00236	CcSEcCtD
Alendronate—Anaemia—Irinotecan—stomach cancer	0.000877	0.00235	CcSEcCtD
Alendronate—Abdominal discomfort—Capecitabine—stomach cancer	0.000874	0.00234	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000857	0.00404	CbGpPWpGaD
Alendronate—Malaise—Irinotecan—stomach cancer	0.000855	0.00229	CcSEcCtD
Alendronate—Oesophagitis—Doxorubicin—stomach cancer	0.000855	0.00229	CcSEcCtD
Alendronate—Vertigo—Irinotecan—stomach cancer	0.000852	0.00228	CcSEcCtD
Alendronate—Anaemia—Fluorouracil—stomach cancer	0.00084	0.00225	CcSEcCtD
Alendronate—Photosensitivity—Epirubicin—stomach cancer	0.000836	0.00224	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000832	0.00223	CcSEcCtD
Alendronate—Photosensitivity reaction—Capecitabine—stomach cancer	0.000832	0.00223	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000822	0.00387	CbGpPWpGaD
Alendronate—Stomatitis—Docetaxel—stomach cancer	0.000818	0.00219	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000805	0.00216	CcSEcCtD
Alendronate—Discomfort—Irinotecan—stomach cancer	0.000798	0.00214	CcSEcCtD
Alendronate—Stomatitis—Capecitabine—stomach cancer	0.000792	0.00212	CcSEcCtD
Alendronate—Photosensitivity—Doxorubicin—stomach cancer	0.000774	0.00207	CcSEcCtD
Alendronate—Myalgia—Fluorouracil—stomach cancer	0.000773	0.00207	CcSEcCtD
Alendronate—Chest pain—Fluorouracil—stomach cancer	0.000773	0.00207	CcSEcCtD
Alendronate—Infection—Irinotecan—stomach cancer	0.000769	0.00206	CcSEcCtD
Alendronate—Discomfort—Fluorouracil—stomach cancer	0.000764	0.00205	CcSEcCtD
Alendronate—Haemoglobin—Docetaxel—stomach cancer	0.000757	0.00203	CcSEcCtD
Alendronate—Haemorrhage—Docetaxel—stomach cancer	0.000753	0.00202	CcSEcCtD
Alendronate—Oedema peripheral—Docetaxel—stomach cancer	0.000742	0.00199	CcSEcCtD
Alendronate—Infection—Fluorouracil—stomach cancer	0.000737	0.00197	CcSEcCtD
Alendronate—Haemoglobin—Capecitabine—stomach cancer	0.000733	0.00196	CcSEcCtD
Alendronate—Haemorrhage—Capecitabine—stomach cancer	0.000729	0.00195	CcSEcCtD
Alendronate—Oedema peripheral—Capecitabine—stomach cancer	0.000718	0.00192	CcSEcCtD
Alendronate—ATP6V1A—Disease—PGLS—stomach cancer	0.000713	0.00336	CbGpPWpGaD
Alendronate—Erythema multiforme—Docetaxel—stomach cancer	0.000712	0.00191	CcSEcCtD
Alendronate—FDPS—Metabolism—ACAD8—stomach cancer	0.000707	0.00333	CbGpPWpGaD
Alendronate—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000707	0.00189	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000691	0.00325	CbGpPWpGaD
Alendronate—Erythema multiforme—Capecitabine—stomach cancer	0.00069	0.00185	CcSEcCtD
Alendronate—Dyspepsia—Irinotecan—stomach cancer	0.000681	0.00183	CcSEcCtD
Alendronate—ATP6V1A—Disease—RBP1—stomach cancer	0.000681	0.0032	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP9—stomach cancer	0.000679	0.0032	CbGpPWpGaD
Alendronate—Asthma—Methotrexate—stomach cancer	0.000678	0.00182	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000676	0.00181	CcSEcCtD
Alendronate—Dry skin—Epirubicin—stomach cancer	0.000673	0.0018	CcSEcCtD
Alendronate—Alopecia—Docetaxel—stomach cancer	0.000666	0.00178	CcSEcCtD
Alendronate—Constipation—Irinotecan—stomach cancer	0.000662	0.00177	CcSEcCtD
Alendronate—Pain—Irinotecan—stomach cancer	0.000662	0.00177	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000661	0.00177	CcSEcCtD
Alendronate—Erythema—Docetaxel—stomach cancer	0.000656	0.00176	CcSEcCtD
Alendronate—Dyspepsia—Fluorouracil—stomach cancer	0.000653	0.00175	CcSEcCtD
Alendronate—Abdominal discomfort—Methotrexate—stomach cancer	0.00065	0.00174	CcSEcCtD
Alendronate—Gastritis—Epirubicin—stomach cancer	0.00065	0.00174	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.00065	0.00306	CbGpPWpGaD
Alendronate—Alopecia—Capecitabine—stomach cancer	0.000644	0.00173	CcSEcCtD
Alendronate—Dysgeusia—Docetaxel—stomach cancer	0.000642	0.00172	CcSEcCtD
Alendronate—Abdominal distension—Epirubicin—stomach cancer	0.000639	0.00171	CcSEcCtD
Alendronate—Feeling abnormal—Irinotecan—stomach cancer	0.000638	0.00171	CcSEcCtD
Alendronate—Erythema—Capecitabine—stomach cancer	0.000635	0.0017	CcSEcCtD
Alendronate—Dysphagia—Epirubicin—stomach cancer	0.000635	0.0017	CcSEcCtD
Alendronate—Asthma—Epirubicin—stomach cancer	0.000635	0.0017	CcSEcCtD
Alendronate—Pain—Fluorouracil—stomach cancer	0.000634	0.0017	CcSEcCtD
Alendronate—Gastrointestinal pain—Irinotecan—stomach cancer	0.000633	0.0017	CcSEcCtD
Alendronate—Muscle spasms—Docetaxel—stomach cancer	0.00063	0.00169	CcSEcCtD
Alendronate—FDPS—Metabolism—GMPR2—stomach cancer	0.00063	0.00297	CbGpPWpGaD
Alendronate—Flatulence—Capecitabine—stomach cancer	0.000626	0.00168	CcSEcCtD
Alendronate—Dry skin—Doxorubicin—stomach cancer	0.000623	0.00167	CcSEcCtD
Alendronate—Dysgeusia—Capecitabine—stomach cancer	0.000622	0.00167	CcSEcCtD
Alendronate—Photosensitivity reaction—Methotrexate—stomach cancer	0.000619	0.00166	CcSEcCtD
Alendronate—Abdominal pain—Irinotecan—stomach cancer	0.000612	0.00164	CcSEcCtD
Alendronate—Body temperature increased—Irinotecan—stomach cancer	0.000612	0.00164	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000612	0.00164	CcSEcCtD
Alendronate—Feeling abnormal—Fluorouracil—stomach cancer	0.000611	0.00164	CcSEcCtD
Alendronate—Muscle spasms—Capecitabine—stomach cancer	0.00061	0.00163	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000608	0.00286	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FBP1—stomach cancer	0.000607	0.00286	CbGpPWpGaD
Alendronate—Anaemia—Docetaxel—stomach cancer	0.000606	0.00162	CcSEcCtD
Alendronate—Gastritis—Doxorubicin—stomach cancer	0.000601	0.00161	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000601	0.00283	CbGpPWpGaD
Alendronate—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.0006	0.00161	CcSEcCtD
Alendronate—Abdominal distension—Doxorubicin—stomach cancer	0.000591	0.00158	CcSEcCtD
Alendronate—Stomatitis—Methotrexate—stomach cancer	0.00059	0.00158	CcSEcCtD
Alendronate—Ill-defined disorder—Capecitabine—stomach cancer	0.000589	0.00158	CcSEcCtD
Alendronate—Urticaria—Fluorouracil—stomach cancer	0.000589	0.00158	CcSEcCtD
Alendronate—Asthma—Doxorubicin—stomach cancer	0.000587	0.00157	CcSEcCtD
Alendronate—Dysphagia—Doxorubicin—stomach cancer	0.000587	0.00157	CcSEcCtD
Alendronate—Anaemia—Capecitabine—stomach cancer	0.000587	0.00157	CcSEcCtD
Alendronate—Body temperature increased—Fluorouracil—stomach cancer	0.000586	0.00157	CcSEcCtD
Alendronate—Photosensitivity reaction—Epirubicin—stomach cancer	0.000579	0.00155	CcSEcCtD
Alendronate—FDPS—Metabolism—SUCLG1—stomach cancer	0.000576	0.00271	CbGpPWpGaD
Alendronate—FDPS—Metabolism—IDH3B—stomach cancer	0.000576	0.00271	CbGpPWpGaD
Alendronate—Malaise—Capecitabine—stomach cancer	0.000573	0.00153	CcSEcCtD
Alendronate—Vertigo—Capecitabine—stomach cancer	0.00057	0.00153	CcSEcCtD
Alendronate—Hypersensitivity—Irinotecan—stomach cancer	0.00057	0.00153	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000561	0.0015	CcSEcCtD
Alendronate—Myalgia—Docetaxel—stomach cancer	0.000558	0.0015	CcSEcCtD
Alendronate—Chest pain—Docetaxel—stomach cancer	0.000558	0.0015	CcSEcCtD
Alendronate—Asthenia—Irinotecan—stomach cancer	0.000555	0.00149	CcSEcCtD
Alendronate—Stomatitis—Epirubicin—stomach cancer	0.000552	0.00148	CcSEcCtD
Alendronate—Hypersensitivity—Fluorouracil—stomach cancer	0.000546	0.00146	CcSEcCtD
Alendronate—Haemoglobin—Methotrexate—stomach cancer	0.000546	0.00146	CcSEcCtD
Alendronate—FDPS—SREBP signalling—PIK3CA—stomach cancer	0.000544	0.00256	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—MAPK3—stomach cancer	0.000544	0.00256	CbGpPWpGaD
Alendronate—Haemorrhage—Methotrexate—stomach cancer	0.000543	0.00145	CcSEcCtD
Alendronate—ATP6V1A—Disease—PGAM1—stomach cancer	0.000541	0.00255	CbGpPWpGaD
Alendronate—Chest pain—Capecitabine—stomach cancer	0.000541	0.00145	CcSEcCtD
Alendronate—Myalgia—Capecitabine—stomach cancer	0.000541	0.00145	CcSEcCtD
Alendronate—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000536	0.00144	CcSEcCtD
Alendronate—FDPS—Metabolism—NDUFV1—stomach cancer	0.000536	0.00252	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NDUFS1—stomach cancer	0.000536	0.00252	CbGpPWpGaD
Alendronate—Discomfort—Capecitabine—stomach cancer	0.000534	0.00143	CcSEcCtD
Alendronate—Infection—Docetaxel—stomach cancer	0.000532	0.00142	CcSEcCtD
Alendronate—Diarrhoea—Irinotecan—stomach cancer	0.00053	0.00142	CcSEcCtD
Alendronate—Pruritus—Fluorouracil—stomach cancer	0.000525	0.00141	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000524	0.00247	CbGpPWpGaD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000519	0.00139	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—MAPK1—stomach cancer	0.000518	0.00244	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—WIF1—stomach cancer	0.000516	0.00243	CbGpPWpGaD
Alendronate—Infection—Capecitabine—stomach cancer	0.000515	0.00138	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—stomach cancer	0.000513	0.00137	CcSEcCtD
Alendronate—Dizziness—Irinotecan—stomach cancer	0.000512	0.00137	CcSEcCtD
Alendronate—Haemoglobin—Epirubicin—stomach cancer	0.000511	0.00137	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—stomach cancer	0.00051	0.00137	CcSEcCtD
Alendronate—Haemorrhage—Epirubicin—stomach cancer	0.000508	0.00136	CcSEcCtD
Alendronate—Diarrhoea—Fluorouracil—stomach cancer	0.000507	0.00136	CcSEcCtD
Alendronate—Oedema peripheral—Epirubicin—stomach cancer	0.000501	0.00134	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—KISS1R—stomach cancer	0.0005	0.00235	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GLI3—stomach cancer	0.0005	0.00235	CbGpPWpGaD
Alendronate—Vomiting—Irinotecan—stomach cancer	0.000492	0.00132	CcSEcCtD
Alendronate—Dizziness—Fluorouracil—stomach cancer	0.00049	0.00131	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—KRAS—stomach cancer	0.000489	0.0023	CbGpPWpGaD
Alendronate—Rash—Irinotecan—stomach cancer	0.000488	0.00131	CcSEcCtD
Alendronate—Dermatitis—Irinotecan—stomach cancer	0.000488	0.00131	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000488	0.00131	CcSEcCtD
Alendronate—Headache—Irinotecan—stomach cancer	0.000485	0.0013	CcSEcCtD
Alendronate—ATP6V1A—Disease—RPL13—stomach cancer	0.000485	0.00228	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPL18—stomach cancer	0.000485	0.00228	CbGpPWpGaD
Alendronate—Erythema multiforme—Epirubicin—stomach cancer	0.00048	0.00129	CcSEcCtD
Alendronate—Alopecia—Methotrexate—stomach cancer	0.00048	0.00128	CcSEcCtD
Alendronate—FDPS—Metabolism—PGLS—stomach cancer	0.000478	0.00225	CbGpPWpGaD
Alendronate—FDPS—Metabolism—BLVRB—stomach cancer	0.000478	0.00225	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RBP1—stomach cancer	0.000477	0.00224	CbGpPWpGaD
Alendronate—Erythema—Methotrexate—stomach cancer	0.000473	0.00127	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—stomach cancer	0.000473	0.00127	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000472	0.00126	CcSEcCtD
Alendronate—Vomiting—Fluorouracil—stomach cancer	0.000471	0.00126	CcSEcCtD
Alendronate—Dyspepsia—Docetaxel—stomach cancer	0.000471	0.00126	CcSEcCtD
Alendronate—Haemorrhage—Doxorubicin—stomach cancer	0.00047	0.00126	CcSEcCtD
Alendronate—Rash—Fluorouracil—stomach cancer	0.000468	0.00125	CcSEcCtD
Alendronate—Dermatitis—Fluorouracil—stomach cancer	0.000467	0.00125	CcSEcCtD
Alendronate—Headache—Fluorouracil—stomach cancer	0.000465	0.00124	CcSEcCtD
Alendronate—Oedema peripheral—Doxorubicin—stomach cancer	0.000463	0.00124	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—stomach cancer	0.000463	0.00124	CcSEcCtD
Alendronate—Nausea—Irinotecan—stomach cancer	0.00046	0.00123	CcSEcCtD
Alendronate—ATP6V1A—Disease—RNF43—stomach cancer	0.00046	0.00216	CbGpPWpGaD
Alendronate—Pain—Docetaxel—stomach cancer	0.000458	0.00123	CcSEcCtD
Alendronate—Constipation—Docetaxel—stomach cancer	0.000458	0.00123	CcSEcCtD
Alendronate—Dyspepsia—Capecitabine—stomach cancer	0.000456	0.00122	CcSEcCtD
Alendronate—FDPS—Metabolism—PPAP2A—stomach cancer	0.000456	0.00215	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPS15—stomach cancer	0.000452	0.00213	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPS21—stomach cancer	0.000452	0.00213	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PIK3CA—stomach cancer	0.000449	0.00212	CbGpPWpGaD
Alendronate—Alopecia—Epirubicin—stomach cancer	0.000449	0.0012	CcSEcCtD
Alendronate—Erythema multiforme—Doxorubicin—stomach cancer	0.000445	0.00119	CcSEcCtD
Alendronate—Constipation—Capecitabine—stomach cancer	0.000443	0.00119	CcSEcCtD
Alendronate—Pain—Capecitabine—stomach cancer	0.000443	0.00119	CcSEcCtD
Alendronate—Erythema—Epirubicin—stomach cancer	0.000442	0.00118	CcSEcCtD
Alendronate—Feeling abnormal—Docetaxel—stomach cancer	0.000441	0.00118	CcSEcCtD
Alendronate—Nausea—Fluorouracil—stomach cancer	0.00044	0.00118	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—stomach cancer	0.000439	0.00117	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000438	0.00206	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000438	0.00117	CcSEcCtD
Alendronate—Anaemia—Methotrexate—stomach cancer	0.000437	0.00117	CcSEcCtD
Alendronate—Flatulence—Epirubicin—stomach cancer	0.000436	0.00117	CcSEcCtD
Alendronate—Dysgeusia—Epirubicin—stomach cancer	0.000433	0.00116	CcSEcCtD
Alendronate—Feeling abnormal—Capecitabine—stomach cancer	0.000427	0.00114	CcSEcCtD
Alendronate—Malaise—Methotrexate—stomach cancer	0.000426	0.00114	CcSEcCtD
Alendronate—Muscle spasms—Epirubicin—stomach cancer	0.000425	0.00114	CcSEcCtD
Alendronate—Vertigo—Methotrexate—stomach cancer	0.000425	0.00114	CcSEcCtD
Alendronate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000424	0.00113	CcSEcCtD
Alendronate—Abdominal pain—Docetaxel—stomach cancer	0.000423	0.00113	CcSEcCtD
Alendronate—Body temperature increased—Docetaxel—stomach cancer	0.000423	0.00113	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—HRAS—stomach cancer	0.000416	0.00196	CbGpPWpGaD
Alendronate—Alopecia—Doxorubicin—stomach cancer	0.000415	0.00111	CcSEcCtD
Alendronate—Urticaria—Capecitabine—stomach cancer	0.000412	0.0011	CcSEcCtD
Alendronate—Ill-defined disorder—Epirubicin—stomach cancer	0.00041	0.0011	CcSEcCtD
Alendronate—Body temperature increased—Capecitabine—stomach cancer	0.00041	0.0011	CcSEcCtD
Alendronate—Abdominal pain—Capecitabine—stomach cancer	0.00041	0.0011	CcSEcCtD
Alendronate—Erythema—Doxorubicin—stomach cancer	0.000409	0.0011	CcSEcCtD
Alendronate—Anaemia—Epirubicin—stomach cancer	0.000409	0.00109	CcSEcCtD
Alendronate—FDPS—Metabolism—NDUFA2—stomach cancer	0.000406	0.00191	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FBP1—stomach cancer	0.000406	0.00191	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CKB—stomach cancer	0.000406	0.00191	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CA1—stomach cancer	0.000406	0.00191	CbGpPWpGaD
Alendronate—Flatulence—Doxorubicin—stomach cancer	0.000403	0.00108	CcSEcCtD
Alendronate—Chest pain—Methotrexate—stomach cancer	0.000402	0.00108	CcSEcCtD
Alendronate—Myalgia—Methotrexate—stomach cancer	0.000402	0.00108	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—stomach cancer	0.000401	0.00107	CcSEcCtD
Alendronate—Malaise—Epirubicin—stomach cancer	0.000399	0.00107	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—stomach cancer	0.000398	0.00187	CbGpPWpGaD
Alendronate—Discomfort—Methotrexate—stomach cancer	0.000398	0.00106	CcSEcCtD
Alendronate—Vertigo—Epirubicin—stomach cancer	0.000397	0.00106	CcSEcCtD
Alendronate—Hypersensitivity—Docetaxel—stomach cancer	0.000394	0.00106	CcSEcCtD
Alendronate—Muscle spasms—Doxorubicin—stomach cancer	0.000393	0.00105	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—WWOX—stomach cancer	0.000388	0.00183	CbGpPWpGaD
Alendronate—Asthenia—Docetaxel—stomach cancer	0.000384	0.00103	CcSEcCtD
Alendronate—Infection—Methotrexate—stomach cancer	0.000383	0.00103	CcSEcCtD
Alendronate—FDPS—Metabolism—PLIN2—stomach cancer	0.000382	0.0018	CbGpPWpGaD
Alendronate—Hypersensitivity—Capecitabine—stomach cancer	0.000382	0.00102	CcSEcCtD
Alendronate—Ill-defined disorder—Doxorubicin—stomach cancer	0.00038	0.00102	CcSEcCtD
Alendronate—Pruritus—Docetaxel—stomach cancer	0.000379	0.00101	CcSEcCtD
Alendronate—Anaemia—Doxorubicin—stomach cancer	0.000378	0.00101	CcSEcCtD
Alendronate—Chest pain—Epirubicin—stomach cancer	0.000377	0.00101	CcSEcCtD
Alendronate—Myalgia—Epirubicin—stomach cancer	0.000377	0.00101	CcSEcCtD
Alendronate—ATP6V1A—Disease—ALDOB—stomach cancer	0.000375	0.00176	CbGpPWpGaD
Alendronate—Discomfort—Epirubicin—stomach cancer	0.000372	0.000996	CcSEcCtD
Alendronate—Asthenia—Capecitabine—stomach cancer	0.000372	0.000996	CcSEcCtD
Alendronate—FDPS—Metabolism—CA2—stomach cancer	0.000371	0.00175	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.00037	0.00174	CbGpPWpGaD
Alendronate—Malaise—Doxorubicin—stomach cancer	0.000369	0.000988	CcSEcCtD
Alendronate—Vertigo—Doxorubicin—stomach cancer	0.000368	0.000985	CcSEcCtD
Alendronate—ATP6V1A—Disease—RPL15—stomach cancer	0.000367	0.00173	CbGpPWpGaD
Alendronate—Pruritus—Capecitabine—stomach cancer	0.000367	0.000982	CcSEcCtD
Alendronate—Diarrhoea—Docetaxel—stomach cancer	0.000366	0.000981	CcSEcCtD
Alendronate—FDPS—Metabolism—NT5E—stomach cancer	0.000362	0.0017	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PGAM1—stomach cancer	0.000362	0.0017	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRH4—stomach cancer	0.000361	0.0017	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—WIF1—stomach cancer	0.000361	0.0017	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NPM1—stomach cancer	0.000361	0.0017	CbGpPWpGaD
Alendronate—Infection—Epirubicin—stomach cancer	0.000359	0.00096	CcSEcCtD
Alendronate—Diarrhoea—Capecitabine—stomach cancer	0.000355	0.00095	CcSEcCtD
Alendronate—Dizziness—Docetaxel—stomach cancer	0.000354	0.000948	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000351	0.000941	CcSEcCtD
Alendronate—Chest pain—Doxorubicin—stomach cancer	0.000348	0.000933	CcSEcCtD
Alendronate—Myalgia—Doxorubicin—stomach cancer	0.000348	0.000933	CcSEcCtD
Alendronate—ATP6V1A—Disease—RBP4—stomach cancer	0.000348	0.00164	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLCE1—stomach cancer	0.000345	0.00163	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALDH7A1—stomach cancer	0.000345	0.00163	CbGpPWpGaD
Alendronate—Discomfort—Doxorubicin—stomach cancer	0.000344	0.000922	CcSEcCtD
Alendronate—ATP6V1A—Disease—RPS26—stomach cancer	0.000343	0.00161	CbGpPWpGaD
Alendronate—Dizziness—Capecitabine—stomach cancer	0.000343	0.000918	CcSEcCtD
Alendronate—Vomiting—Docetaxel—stomach cancer	0.00034	0.000911	CcSEcCtD
Alendronate—ATP6V1A—Disease—PPIA—stomach cancer	0.00034	0.0016	CbGpPWpGaD
Alendronate—Dyspepsia—Methotrexate—stomach cancer	0.00034	0.000909	CcSEcCtD
Alendronate—Rash—Docetaxel—stomach cancer	0.000337	0.000904	CcSEcCtD
Alendronate—Dermatitis—Docetaxel—stomach cancer	0.000337	0.000903	CcSEcCtD
Alendronate—Headache—Docetaxel—stomach cancer	0.000335	0.000898	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PRKAB1—stomach cancer	0.000333	0.00157	CbGpPWpGaD
Alendronate—Infection—Doxorubicin—stomach cancer	0.000332	0.000889	CcSEcCtD
Alendronate—FDPS—Metabolism—UMPS—stomach cancer	0.000331	0.00156	CbGpPWpGaD
Alendronate—Pain—Methotrexate—stomach cancer	0.00033	0.000883	CcSEcCtD
Alendronate—Vomiting—Capecitabine—stomach cancer	0.000329	0.000882	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000329	0.000881	CcSEcCtD
Alendronate—Rash—Capecitabine—stomach cancer	0.000327	0.000875	CcSEcCtD
Alendronate—Dermatitis—Capecitabine—stomach cancer	0.000326	0.000874	CcSEcCtD
Alendronate—Headache—Capecitabine—stomach cancer	0.000325	0.000869	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—RNF43—stomach cancer	0.000322	0.00152	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KISS1—stomach cancer	0.000322	0.00152	CbGpPWpGaD
Alendronate—Nausea—Docetaxel—stomach cancer	0.000318	0.000851	CcSEcCtD
Alendronate—Feeling abnormal—Methotrexate—stomach cancer	0.000318	0.000851	CcSEcCtD
Alendronate—Dyspepsia—Epirubicin—stomach cancer	0.000318	0.000851	CcSEcCtD
Alendronate—Gastrointestinal pain—Methotrexate—stomach cancer	0.000315	0.000845	CcSEcCtD
Alendronate—Pain—Epirubicin—stomach cancer	0.000309	0.000827	CcSEcCtD
Alendronate—Constipation—Epirubicin—stomach cancer	0.000309	0.000827	CcSEcCtD
Alendronate—Nausea—Capecitabine—stomach cancer	0.000308	0.000824	CcSEcCtD
Alendronate—FDPS—Metabolism—ECHS1—stomach cancer	0.000308	0.00145	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PDHA1—stomach cancer	0.000308	0.00145	CbGpPWpGaD
Alendronate—Urticaria—Methotrexate—stomach cancer	0.000306	0.000821	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—stomach cancer	0.000305	0.000817	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—stomach cancer	0.000305	0.000817	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000304	0.000815	CcSEcCtD
Alendronate—Feeling abnormal—Epirubicin—stomach cancer	0.000297	0.000797	CcSEcCtD
Alendronate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000295	0.000791	CcSEcCtD
Alendronate—Dyspepsia—Doxorubicin—stomach cancer	0.000294	0.000787	CcSEcCtD
Alendronate—ATP6V1A—Disease—AKR1C3—stomach cancer	0.000291	0.00137	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPS19—stomach cancer	0.000291	0.00137	CbGpPWpGaD
Alendronate—FDPS—Metabolism—FADS1—stomach cancer	0.000289	0.00136	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TYMP—stomach cancer	0.000289	0.00136	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FST—stomach cancer	0.000287	0.00135	CbGpPWpGaD
Alendronate—Urticaria—Epirubicin—stomach cancer	0.000287	0.000768	CcSEcCtD
Alendronate—Pain—Doxorubicin—stomach cancer	0.000286	0.000765	CcSEcCtD
Alendronate—Constipation—Doxorubicin—stomach cancer	0.000286	0.000765	CcSEcCtD
Alendronate—Body temperature increased—Epirubicin—stomach cancer	0.000285	0.000764	CcSEcCtD
Alendronate—Abdominal pain—Epirubicin—stomach cancer	0.000285	0.000764	CcSEcCtD
Alendronate—Hypersensitivity—Methotrexate—stomach cancer	0.000284	0.000761	CcSEcCtD
Alendronate—ATP6V1A—Disease—ENO1—stomach cancer	0.000284	0.00134	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000281	0.00132	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GAST—stomach cancer	0.000277	0.0013	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RGS2—stomach cancer	0.000277	0.0013	CbGpPWpGaD
Alendronate—Asthenia—Methotrexate—stomach cancer	0.000277	0.000741	CcSEcCtD
Alendronate—Feeling abnormal—Doxorubicin—stomach cancer	0.000275	0.000737	CcSEcCtD
Alendronate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000273	0.000731	CcSEcCtD
Alendronate—Pruritus—Methotrexate—stomach cancer	0.000273	0.000731	CcSEcCtD
Alendronate—FDPS—Metabolism—SREBF2—stomach cancer	0.000271	0.00128	CbGpPWpGaD
Alendronate—FDPS—Metabolism—RORA—stomach cancer	0.000268	0.00126	CbGpPWpGaD
Alendronate—Hypersensitivity—Epirubicin—stomach cancer	0.000266	0.000712	CcSEcCtD
Alendronate—Urticaria—Doxorubicin—stomach cancer	0.000265	0.000711	CcSEcCtD
Alendronate—Abdominal pain—Doxorubicin—stomach cancer	0.000264	0.000707	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—stomach cancer	0.000264	0.000707	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—stomach cancer	0.000264	0.000707	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGG—stomach cancer	0.000262	0.00124	CbGpPWpGaD
Alendronate—Asthenia—Epirubicin—stomach cancer	0.000259	0.000694	CcSEcCtD
Alendronate—ATP6V1A—Disease—RPS6—stomach cancer	0.000258	0.00121	CbGpPWpGaD
Alendronate—Pruritus—Epirubicin—stomach cancer	0.000255	0.000684	CcSEcCtD
Alendronate—Dizziness—Methotrexate—stomach cancer	0.000255	0.000683	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PRKAA1—stomach cancer	0.000253	0.00119	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CD44—stomach cancer	0.000252	0.00119	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALDOB—stomach cancer	0.000251	0.00118	CbGpPWpGaD
Alendronate—Diarrhoea—Epirubicin—stomach cancer	0.000247	0.000661	CcSEcCtD
Alendronate—Hypersensitivity—Doxorubicin—stomach cancer	0.000246	0.000659	CcSEcCtD
Alendronate—Vomiting—Methotrexate—stomach cancer	0.000245	0.000657	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—RBP4—stomach cancer	0.000244	0.00115	CbGpPWpGaD
Alendronate—Rash—Methotrexate—stomach cancer	0.000243	0.000651	CcSEcCtD
Alendronate—Dermatitis—Methotrexate—stomach cancer	0.000243	0.000651	CcSEcCtD
Alendronate—Headache—Methotrexate—stomach cancer	0.000242	0.000647	CcSEcCtD
Alendronate—Asthenia—Doxorubicin—stomach cancer	0.00024	0.000642	CcSEcCtD
Alendronate—Dizziness—Epirubicin—stomach cancer	0.000239	0.000639	CcSEcCtD
Alendronate—ATP6V1A—Disease—HBEGF—stomach cancer	0.000237	0.00112	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000237	0.00111	CbGpPWpGaD
Alendronate—Pruritus—Doxorubicin—stomach cancer	0.000236	0.000633	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000236	0.00111	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALOX5—stomach cancer	0.000233	0.0011	CbGpPWpGaD
Alendronate—Vomiting—Epirubicin—stomach cancer	0.00023	0.000615	CcSEcCtD
Alendronate—FDPS—Metabolism—DPYD—stomach cancer	0.000229	0.00108	CbGpPWpGaD
Alendronate—Nausea—Methotrexate—stomach cancer	0.000229	0.000614	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—stomach cancer	0.000229	0.000612	CcSEcCtD
Alendronate—Rash—Epirubicin—stomach cancer	0.000228	0.00061	CcSEcCtD
Alendronate—Dermatitis—Epirubicin—stomach cancer	0.000227	0.000609	CcSEcCtD
Alendronate—Headache—Epirubicin—stomach cancer	0.000226	0.000606	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—stomach cancer	0.000222	0.00105	CbGpPWpGaD
Alendronate—Dizziness—Doxorubicin—stomach cancer	0.000221	0.000592	CcSEcCtD
Alendronate—Nausea—Epirubicin—stomach cancer	0.000214	0.000574	CcSEcCtD
Alendronate—ATP6V1A—Disease—PPP2R1A—stomach cancer	0.000214	0.00101	CbGpPWpGaD
Alendronate—Vomiting—Doxorubicin—stomach cancer	0.000212	0.000569	CcSEcCtD
Alendronate—Rash—Doxorubicin—stomach cancer	0.000211	0.000564	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—stomach cancer	0.00021	0.000564	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HSPB1—stomach cancer	0.00021	0.000988	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGTR2—stomach cancer	0.00021	0.000988	CbGpPWpGaD
Alendronate—Headache—Doxorubicin—stomach cancer	0.000209	0.00056	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000208	0.000979	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BMP2—stomach cancer	0.000207	0.000977	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—F2R—stomach cancer	0.000207	0.000977	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKR1C3—stomach cancer	0.000204	0.000961	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTT1—stomach cancer	0.000203	0.000955	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR1A—stomach cancer	0.000202	0.000951	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2A6—stomach cancer	0.000201	0.000944	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SMAD4—stomach cancer	0.000199	0.000936	CbGpPWpGaD
Alendronate—Nausea—Doxorubicin—stomach cancer	0.000198	0.000531	CcSEcCtD
Alendronate—FDPS—Metabolism—AKR1C3—stomach cancer	0.000195	0.000919	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ANXA1—stomach cancer	0.000195	0.000918	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ENO1—stomach cancer	0.00019	0.000895	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRB1—stomach cancer	0.000189	0.000889	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FYN—stomach cancer	0.000189	0.000889	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000187	0.000881	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERCC2—stomach cancer	0.000181	0.000855	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RPS6—stomach cancer	0.00018	0.00085	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGFR2—stomach cancer	0.000177	0.000835	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—stomach cancer	0.000171	0.000803	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CD44—stomach cancer	0.000169	0.000794	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HBEGF—stomach cancer	0.000166	0.000781	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000164	0.00077	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IRS2—stomach cancer	0.000162	0.000764	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CAV1—stomach cancer	0.000157	0.000741	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOA1—stomach cancer	0.000157	0.000739	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRB2—stomach cancer	0.000153	0.000721	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PPP2R1A—stomach cancer	0.00015	0.000706	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6ST—stomach cancer	0.000149	0.000702	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPP2R1A—stomach cancer	0.000143	0.000675	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APC—stomach cancer	0.000143	0.000675	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTP1—stomach cancer	0.000141	0.000662	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SMAD4—stomach cancer	0.000139	0.000656	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—stomach cancer	0.000139	0.000653	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6R—stomach cancer	0.000133	0.000627	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FYN—stomach cancer	0.000132	0.000623	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TYMS—stomach cancer	0.000131	0.000616	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—stomach cancer	0.000129	0.000609	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SERPINE1—stomach cancer	0.000125	0.000587	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGFR2—stomach cancer	0.000124	0.000584	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ERCC2—stomach cancer	0.000122	0.000572	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RHOA—stomach cancer	0.00012	0.000566	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS3—stomach cancer	0.000119	0.00056	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—stomach cancer	0.000114	0.000538	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS2—stomach cancer	0.000114	0.000535	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB2—stomach cancer	0.000111	0.000524	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CAV1—stomach cancer	0.00011	0.000519	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOA1—stomach cancer	0.00011	0.000518	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—stomach cancer	0.000109	0.000512	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAV1—stomach cancer	0.000105	0.000496	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOA1—stomach cancer	0.000105	0.000495	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKCB—stomach cancer	0.000105	0.000494	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6ST—stomach cancer	0.000104	0.000492	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN1B—stomach cancer	0.000103	0.000485	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	0.000101	0.000474	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APC—stomach cancer	0.0001	0.000473	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN1A—stomach cancer	9.51e-05	0.000448	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6R—stomach cancer	9.32e-05	0.000439	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARG—stomach cancer	9.26e-05	0.000436	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SERPINE1—stomach cancer	8.73e-05	0.000411	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—stomach cancer	8.49e-05	0.0004	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RHOA—stomach cancer	8.42e-05	0.000396	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOS3—stomach cancer	8.33e-05	0.000392	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—stomach cancer	8.33e-05	0.000392	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAPK3—stomach cancer	8.11e-05	0.000382	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NOS3—stomach cancer	7.97e-05	0.000375	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—stomach cancer	7.89e-05	0.000371	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB2—stomach cancer	7.79e-05	0.000367	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAPK1—stomach cancer	7.72e-05	0.000363	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—stomach cancer	7.71e-05	0.000363	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—stomach cancer	7.39e-05	0.000348	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KRAS—stomach cancer	7.29e-05	0.000343	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—stomach cancer	7.29e-05	0.000343	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1B—stomach cancer	7.22e-05	0.00034	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCND1—stomach cancer	6.89e-05	0.000324	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUN—stomach cancer	6.87e-05	0.000324	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CA—stomach cancer	6.7e-05	0.000315	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—stomach cancer	6.69e-05	0.000315	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1A—stomach cancer	6.66e-05	0.000314	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK8—stomach cancer	6.5e-05	0.000306	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HRAS—stomach cancer	6.19e-05	0.000292	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—stomach cancer	6e-05	0.000283	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—stomach cancer	5.94e-05	0.00028	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—stomach cancer	5.93e-05	0.000279	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK3—stomach cancer	5.68e-05	0.000267	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—stomach cancer	5.52e-05	0.00026	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAPK1—stomach cancer	5.4e-05	0.000254	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—stomach cancer	5.4e-05	0.000254	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KRAS—stomach cancer	5.1e-05	0.00024	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CA—stomach cancer	4.69e-05	0.000221	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—stomach cancer	4.54e-05	0.000214	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CA—stomach cancer	4.48e-05	0.000211	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRAS—stomach cancer	4.34e-05	0.000204	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—stomach cancer	4.15e-05	0.000195	CbGpPWpGaD
